BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34236019)

  • 1. Reductions in positive
    Goodenough D; Sefton S; Overton E; Smith E; Kraft CS; Varkey JB; Fridkin SK
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):935-938. PubMed ID: 34236019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Healthcare Facility-Onset Clostridioides difficile Infection and the Impact of Testing Schemes in an Acute Care Hospital System in New York City, 2016-2019.
    Episcopia B; Gupta A; Fornek M; Kaminski M; Malik S; Sunny S; Landman D; Xavier G; Quale J
    Am J Infect Control; 2021 Oct; 49(10):1262-1266. PubMed ID: 33716096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in
    Skinner AM; Yu B; Cheknis A; Pacheco SM; Gerding DN; Johnson S
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1148-1153. PubMed ID: 32576334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of testing methods on incidence of
    McCauley BP; Evans ME; Simbartl LA; Gamage SD; Kralovic SM; Roselle GA
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):461-463. PubMed ID: 33185177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
    Parnell JM; Fazili I; Bloch SC; Lacy DB; Garcia-Lopez VA; Bernard R; Skaar EP; Edwards KM; Nicholson MR
    J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):378-383. PubMed ID: 32925555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
    Cook PP; Nichols S; Coogan M; Opera J; DeHart M
    Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of changing reflexive to clinician-ordered
    Sullivan EL; Majumdar R; Ortiz C; Riggs PK; Crum-Cianflone NF
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):684-690. PubMed ID: 32279670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
    Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
    J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Clostridioides difficile diagnosis before and after a change in testing algorithm.
    Turner DP; Thorburn SJ; Crowe A; Jardine D; Timmins C
    J Microbiol Methods; 2021 May; 184():106189. PubMed ID: 33689797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
    Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
    Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
    Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
    J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of molecular testing on reported
    Ilieş I; Benneyan JC; Jabur TBC; Baker AW; Anderson DJ
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):306-312. PubMed ID: 31852562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
    Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
    Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant
    Lenggenhager L; Zanella MC; Poncet A; Kaiser L; Schrenzel J
    BMJ Open; 2020 Sep; 10(9):e036342. PubMed ID: 32928850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of
    Dumm RE; Burnham C-AD; Hink T; Reske KA; Struttmann E; Iqbal ZH; Cass C; Kwon JH; Olsen MA; Dubberke ER
    J Clin Microbiol; 2024 Jan; 62(1):e0103723. PubMed ID: 38078766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.